Trendlines Group (SG:42T) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Trendlines Group Ltd. has released its unaudited financial statements for the first half of 2024 and announced an upcoming Special General Meeting to discuss a new share subscription proposal. The company also highlighted the approval of investments in nine portfolio companies, with key achievements such as Arcuro Medical’s milestone in surgical cases and Nasotrak Medical’s patent grant and certification. Additionally, BeCapio Ltd. has welcomed a new Chair to its board.
For further insights into SG:42T stock, check out TipRanks’ Stock Analysis page.